Switching to the 2-drug regimen of dolutegravir/lamivudine

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the International AIDS Society 2021-07, Vol.24 (S4), p.13
Hauptverfasser: Llibre, J.M, Alves, C, Cheng, C-Y, Osiyemi, O, Galera, C, Hocqueloux, L, Maggiolo, F, Degen, O, Blair, E, Wynne, B, Oyee, J, Underwood, M, Curtis, L, Bontempo, G, van Wyk, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue S4
container_start_page 13
container_title Journal of the International AIDS Society
container_volume 24
creator Llibre, J.M
Alves, C
Cheng, C-Y
Osiyemi, O
Galera, C
Hocqueloux, L
Maggiolo, F
Degen, O
Blair, E
Wynne, B
Oyee, J
Underwood, M
Curtis, L
Bontempo, G
van Wyk, J
description
doi_str_mv 10.1002/jia2.25755
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A672359363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A672359363</galeid><sourcerecordid>A672359363</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1363-e602f8a498f876f1438e1f53be2382a1637640d25363154078aa644c1d12b2f63</originalsourceid><addsrcrecordid>eNpt0E1LxDAQBuAgCq6rF39BQfDW3WTy0dTbsvgFCx7U85JtJ2mWNoU2Xf--FT1UKHOYYXjeOQwht4yuGKWwPnoDK5CZlGdkwTKpU1ASzifzJbnq-yOlCrTIF-Th_cvHovLBJbFNYoUJpGU3uKRD5xsMSWuTsq2HiK4zJ9-ta9P401D6gNfkwpq6x5u_viSfT48f25d09_b8ut3sUse44ikqClYbkWurM2WZ4BqZlfyAwDUYpnimBC1BjphJQTNtjBKiYCWDA1jFl-Tu964zNe59sG3sTNH4vthvVAZc5mNyVOmMchiwM3Ub0Ppx_c-vZvxYJTa-mA3cTwIVmjpW_c9nfBv6KfwGn89ylg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Switching to the 2-drug regimen of dolutegravir/lamivudine</title><source>Wiley Journals</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Llibre, J.M ; Alves, C ; Cheng, C-Y ; Osiyemi, O ; Galera, C ; Hocqueloux, L ; Maggiolo, F ; Degen, O ; Blair, E ; Wynne, B ; Oyee, J ; Underwood, M ; Curtis, L ; Bontempo, G ; van Wyk, J</creator><creatorcontrib>Llibre, J.M ; Alves, C ; Cheng, C-Y ; Osiyemi, O ; Galera, C ; Hocqueloux, L ; Maggiolo, F ; Degen, O ; Blair, E ; Wynne, B ; Oyee, J ; Underwood, M ; Curtis, L ; Bontempo, G ; van Wyk, J</creatorcontrib><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1002/jia2.25755</identifier><language>eng</language><publisher>John Wiley &amp; Sons, Inc</publisher><subject>Comparative analysis ; Development and progression ; Drug therapy ; Drug therapy, Combination ; HIV infection</subject><ispartof>Journal of the International AIDS Society, 2021-07, Vol.24 (S4), p.13</ispartof><rights>COPYRIGHT 2021 John Wiley &amp; Sons, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Llibre, J.M</creatorcontrib><creatorcontrib>Alves, C</creatorcontrib><creatorcontrib>Cheng, C-Y</creatorcontrib><creatorcontrib>Osiyemi, O</creatorcontrib><creatorcontrib>Galera, C</creatorcontrib><creatorcontrib>Hocqueloux, L</creatorcontrib><creatorcontrib>Maggiolo, F</creatorcontrib><creatorcontrib>Degen, O</creatorcontrib><creatorcontrib>Blair, E</creatorcontrib><creatorcontrib>Wynne, B</creatorcontrib><creatorcontrib>Oyee, J</creatorcontrib><creatorcontrib>Underwood, M</creatorcontrib><creatorcontrib>Curtis, L</creatorcontrib><creatorcontrib>Bontempo, G</creatorcontrib><creatorcontrib>van Wyk, J</creatorcontrib><title>Switching to the 2-drug regimen of dolutegravir/lamivudine</title><title>Journal of the International AIDS Society</title><subject>Comparative analysis</subject><subject>Development and progression</subject><subject>Drug therapy</subject><subject>Drug therapy, Combination</subject><subject>HIV infection</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpt0E1LxDAQBuAgCq6rF39BQfDW3WTy0dTbsvgFCx7U85JtJ2mWNoU2Xf--FT1UKHOYYXjeOQwht4yuGKWwPnoDK5CZlGdkwTKpU1ASzifzJbnq-yOlCrTIF-Th_cvHovLBJbFNYoUJpGU3uKRD5xsMSWuTsq2HiK4zJ9-ta9P401D6gNfkwpq6x5u_viSfT48f25d09_b8ut3sUse44ikqClYbkWurM2WZ4BqZlfyAwDUYpnimBC1BjphJQTNtjBKiYCWDA1jFl-Tu964zNe59sG3sTNH4vthvVAZc5mNyVOmMchiwM3Ub0Ppx_c-vZvxYJTa-mA3cTwIVmjpW_c9nfBv6KfwGn89ylg</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Llibre, J.M</creator><creator>Alves, C</creator><creator>Cheng, C-Y</creator><creator>Osiyemi, O</creator><creator>Galera, C</creator><creator>Hocqueloux, L</creator><creator>Maggiolo, F</creator><creator>Degen, O</creator><creator>Blair, E</creator><creator>Wynne, B</creator><creator>Oyee, J</creator><creator>Underwood, M</creator><creator>Curtis, L</creator><creator>Bontempo, G</creator><creator>van Wyk, J</creator><general>John Wiley &amp; Sons, Inc</general><scope/></search><sort><creationdate>20210701</creationdate><title>Switching to the 2-drug regimen of dolutegravir/lamivudine</title><author>Llibre, J.M ; Alves, C ; Cheng, C-Y ; Osiyemi, O ; Galera, C ; Hocqueloux, L ; Maggiolo, F ; Degen, O ; Blair, E ; Wynne, B ; Oyee, J ; Underwood, M ; Curtis, L ; Bontempo, G ; van Wyk, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1363-e602f8a498f876f1438e1f53be2382a1637640d25363154078aa644c1d12b2f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Comparative analysis</topic><topic>Development and progression</topic><topic>Drug therapy</topic><topic>Drug therapy, Combination</topic><topic>HIV infection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Llibre, J.M</creatorcontrib><creatorcontrib>Alves, C</creatorcontrib><creatorcontrib>Cheng, C-Y</creatorcontrib><creatorcontrib>Osiyemi, O</creatorcontrib><creatorcontrib>Galera, C</creatorcontrib><creatorcontrib>Hocqueloux, L</creatorcontrib><creatorcontrib>Maggiolo, F</creatorcontrib><creatorcontrib>Degen, O</creatorcontrib><creatorcontrib>Blair, E</creatorcontrib><creatorcontrib>Wynne, B</creatorcontrib><creatorcontrib>Oyee, J</creatorcontrib><creatorcontrib>Underwood, M</creatorcontrib><creatorcontrib>Curtis, L</creatorcontrib><creatorcontrib>Bontempo, G</creatorcontrib><creatorcontrib>van Wyk, J</creatorcontrib><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Llibre, J.M</au><au>Alves, C</au><au>Cheng, C-Y</au><au>Osiyemi, O</au><au>Galera, C</au><au>Hocqueloux, L</au><au>Maggiolo, F</au><au>Degen, O</au><au>Blair, E</au><au>Wynne, B</au><au>Oyee, J</au><au>Underwood, M</au><au>Curtis, L</au><au>Bontempo, G</au><au>van Wyk, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Switching to the 2-drug regimen of dolutegravir/lamivudine</atitle><jtitle>Journal of the International AIDS Society</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>24</volume><issue>S4</issue><spage>13</spage><pages>13-</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1002/jia2.25755</doi></addata></record>
fulltext fulltext
identifier ISSN: 1758-2652
ispartof Journal of the International AIDS Society, 2021-07, Vol.24 (S4), p.13
issn 1758-2652
1758-2652
language eng
recordid cdi_gale_infotracmisc_A672359363
source Wiley Journals; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central
subjects Comparative analysis
Development and progression
Drug therapy
Drug therapy, Combination
HIV infection
title Switching to the 2-drug regimen of dolutegravir/lamivudine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A42%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Switching%20to%20the%202-drug%20regimen%20of%20dolutegravir/lamivudine&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Llibre,%20J.M&rft.date=2021-07-01&rft.volume=24&rft.issue=S4&rft.spage=13&rft.pages=13-&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1002/jia2.25755&rft_dat=%3Cgale%3EA672359363%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A672359363&rfr_iscdi=true